Shelve the Tylenol? LSD Microdoses Work as Painkillers
Last reviewed and updated: July 5, 2026
Key Takeaways
| Study finding | A 2025 study found LSD microdoses produced measurable analgesic effects in healthy volunteers — reducing pain sensitivity in standardized pain tolerance tests. |
| Mechanism | LSD’s 5-HT2A serotonin receptor activity is present in pain processing pathways, providing a pharmacological explanation for the analgesic effect. |
| Sub-perceptual doses | The analgesic effect appears to be achievable at doses too low to produce psychedelic effects — meaning pain relief may not require a full psychedelic experience. |
| Cluster headache history | The Clusterbusters community has documented sub-perceptual LSD doses breaking cluster headache cycles for decades — a real-world preview of what this research is now confirming in the lab. |
| Not replacing Tylenol | LSD microdosing for pain remains illegal in most jurisdictions and is far from clinical adoption — but the finding opens a research direction with potentially significant implications. |
Psychedelics may help people endure discomfort and pain. Studies in the 1960s and ’70 showed LSD had killed pain in dying patients. Today, it looks like LSD microdoses could do the same. And, with microdoses, you don’t have to have a full-on trip to kill the pain.
A study explored the effects of LSD microdoses on pain perception in healthy volunteers. Published in the Journal of Psychopharmacology, this study looked at 5, 10, and 20mcg doses of LSD compared to a placebo.
The researchers found that 20 mcg significantly increased the time that participants could tolerate exposure to cold water. The water was only a few degrees above freezing. Researchers asked people to dunk their hand “until you cannot take it anymore.”
The scientists noted that 20 mcg decreased their subjective levels of pain and unpleasantness.
This dose elevated blood pressure but within the normal range. It also slightly increased ratings of anxiety and dissociation.
It seems like a stunning result. It’s not, or not entirely. “LSD is just a trippy kind of Tylenol” is actually old news. Back when the Beatles were putting out new music and studying psychedelics was easier, researchers tested LSD vs. opioids in treating pain in dying people. One hundred mics of LSD eased people’s suffering–and it did it better and longer than the opioid.
RELATED: MindMed Just Dosed Their First Patient in LSD Clinical Trial for Anxiety
The problem was that patients didn’t like tripping very much, and many refused a second dose.
The researchers in the modern study deemed that 20 mcg was low enough that no psychedelic effects would occur. However, it was high enough to offer people significant pain-relieving effects.
This study underscores that 20 mcg of LSD could deliver similar analgesic effects as opioids like oxycodone and morphine. Many people abuse — and become addicted to — prescription opioids like oxycodone. These drugs are significant contributors to the opioid crisis, which has seen worrying spikes in the number of people abusing, becoming addicted to, and dying from opioid use.
RELATED: How To Microdose Shrooms Effectively
These studies have demonstrated that the effects of microdosing can’t be completely down to the placebo effect. Further research is necessary. But the future of psychedelic therapy could bring exciting no benefits to people worldwide–in ways that most people don’t think about.
Pain is a huge part of psychedelic research. And it’s not explored enough. Regular people have found that LSD can wipe out cluster headaches, the most awful brain-pain there is.
It’s hard to know what are the real effect of psychedelics and what’s just hype–or, on the other hand, scare tactics. People have recently said that DMT puts you in touch with aliens. We happen to believe that seeing E.T. on DMT is highly unlikely; though big if true. And in the ’70s, haters said LSD makes people jump out of windows. Attempted flight is not usually what happens on LSD, in our experience. But it’s worth saying here that, if you think you can fly while on LSD, try taking off from the ground first instead of the eighth floor balcony.
So does LSD work as a painkiller? The key, in our opinion? Intention.
If you say to yourself: How long could I stand being exposed to cold water? And you answered: only a little while–that’s likely the answer. On the other hand, if you told yourself: this LSD will strengthen and fortify me to endure a plunge in an ice bucket–there’s a high chance that’ll be true.
2026 Update
A 2025 study added LSD to the growing list of psychedelics with documented analgesic properties. Researchers tested LSD microdoses in healthy volunteers using standardized pain tolerance measures and found statistically significant reductions in pain sensitivity at doses well below the psychedelic threshold. The mechanism is pharmacologically plausible: the 5-HT2A serotonin receptor that LSD primarily targets is expressed in pain processing pathways throughout the central and peripheral nervous system. This is the same receptor pathway that makes triptans (like sumatriptan) effective for migraine — LSD appears to access similar analgesic mechanisms through the same receptor family.
The cluster headache community has known something like this for decades. The Clusterbusters patient network has documented sub-perceptual LSD and psilocybin doses breaking cluster cycles since the early 2000s — real-world evidence that preceded any formal research. What’s new is the controlled-study confirmation of the analgesic mechanism. Definium Therapeutics’ Phase 3 completion of DT120 (an LSD compound) in June 2026 didn’t target pain specifically, but its success creates a regulatory framework that could eventually extend to pain indications. Psilocybin’s Phase 2 results for fibromyalgia in 2025 reinforce the broader picture: serotonergic psychedelics appear to have real and underexplored analgesic properties that go well beyond their psychiatric applications.
Frequently Asked Questions
- Do LSD microdoses work as painkillers?
- A 2025 controlled study found LSD microdoses produced measurable analgesic effects in healthy volunteers — reducing pain sensitivity in standardized pain tolerance tests at doses below the psychedelic threshold. This is preliminary evidence in non-pain patients; clinical applications for chronic pain conditions haven’t been tested in large trials. The finding is significant as a research direction, not yet as a clinical recommendation.
- How would LSD reduce pain?
- LSD primarily targets the 5-HT2A serotonin receptor, which is expressed in pain processing pathways in both the central and peripheral nervous system. This is the same receptor family targeted by triptans (migraine treatments). The analgesic effect appears achievable at sub-psychedelic doses, suggesting the pain-modulating mechanism may be separable from the psychedelic experience.
- Can LSD microdoses help with migraines or cluster headaches?
- The real-world evidence from the Clusterbusters patient community (decades of self-reported data) strongly suggests yes for cluster headaches. The 2024 psilocybin migraine Phase 2 study showed strong results. The 2025 LSD analgesic study provides a mechanism that applies to both. However, no large RCT has specifically tested LSD microdoses for migraine or cluster headache in a clinical setting. The research direction is strong; clinical adoption is years away.
- Is using LSD for pain legal?
- LSD remains Schedule I under U.S. federal law — illegal for any use. The one exception: Definium Therapeutics’ DT120 (an LSD compound) is in clinical development, and its Phase 3 completion in June 2026 may eventually create a legal pathway for LSD-based treatments if the FDA approves it. For now, self-medicating with LSD for pain carries legal risks regardless of the emerging research.
RELATED READING: Ketamine Therapy | Psilocybin Therapy | Psychedelic Therapy
